Literature DB >> 26868618

Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.

Kristina Jonsson-Schmunk1, Piynauch Wonganan1, Jin Huk Choi1, Shellie M Callahan1, Maria A Croyle2.   

Abstract

Landmark studies describing the effect of microbial infection on the expression and activity of hepatic CYP3A used bacterial lipopolysaccharide as a model antigen. Our efforts to determine whether these findings were translatable to viral infections led us to observations suggesting that engagement of integrin receptors is key in the initiation of processes responsible for changes in hepatic CYP3A4 during infection and inflammation. Studies outlined in this article were designed to evaluate whether engagement of integrins, receptors commonly used by a variety of microbes to enter cellular targets, is vital in the regulation of CYP3A in the presence and absence of virus infection. Mice infected with a recombinant adenovirus (AdlacZ) experienced a 70% reduction in hepatic CYP3A catalytic activity. Infection with a mutant virus with integrin-binding arginine-glycine-aspartic acid (RGD) sequences deleted from the penton base protein of the virus capsid (AdΔRGD) did not alter CYP3A activity. CYP3A mRNA and protein levels in AdlacZ-treated animals were also suppressed, whereas those of mice given AdΔRGD were not significantly different from uninfected control mice. Silencing of the integrinβ-subunit reverted adenovirus-mediated CYP3A4 suppression in vitro. Silencing of theα-subunit did not. Suppression of integrin subunits had a profound effect on nuclear receptors pregnane X receptor and constitutive androstane receptor, whereas retinoid X receptorαwas largely unaffected. To our knowledge, this is the first time that extracellular receptors, like integrins, have been indicated in the regulation of CYP3A. This finding has several implications owing to the important role of integrins in normal physiologic process and in many disease states.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26868618      PMCID: PMC4851307          DOI: 10.1124/dmd.115.068874

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  64 in total

Review 1.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

2.  Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C.

Authors:  Xunshan Ding; Jeff L Staudinger
Journal:  Biochem Pharmacol       Date:  2005-01-21       Impact factor: 5.858

Review 3.  Integrin structure, activation, and interactions.

Authors:  Iain D Campbell; Martin J Humphries
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

4.  Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon).

Authors:  Ilona Brändlin; Tim Eiseler; Rüdiger Salowsky; Franz-Josef Johannes
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

Review 5.  The current state of serum biomarkers of hepatotoxicity.

Authors:  Josef Ozer; Marcia Ratner; Martin Shaw; Wendy Bailey; Shelli Schomaker
Journal:  Toxicology       Date:  2007-12-05       Impact factor: 4.221

6.  Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.

Authors:  Pranav Shah; Tao Guo; David D Moore; Romi Ghose
Journal:  Drug Metab Dispos       Date:  2013-11-05       Impact factor: 3.922

7.  Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.

Authors:  Marina Kacevska; Andre Mahns; Rohini Sharma; Stephen J Clarke; Graham R Robertson; Christopher Liddle
Journal:  Pharm Res       Date:  2013-04-20       Impact factor: 4.200

8.  Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver.

Authors:  De-Xiang Xu; Wei Wei; Mei-Fang Sun; Cheng-Yi Wu; Jian-Ping Wang; Ling-Zhen Wei; Cheng-Fan Zhou
Journal:  Free Radic Biol Med       Date:  2004-07-01       Impact factor: 7.376

Review 9.  Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression.

Authors:  Satyanarayana R Pondugula; Hanqing Dong; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-08       Impact factor: 4.481

10.  Autophosphorylation properties of inactive and active JNK2.

Authors:  Genaro Pimienta; Scott B Ficarro; Gustavo J Gutierrez; Anindita Bhoumik; Eric C Peters; Ze'ev Ronai; Jaime Pascual
Journal:  Cell Cycle       Date:  2007-05-10       Impact factor: 4.534

View more
  3 in total

1.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

2.  Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.

Authors:  Kristina Jonsson-Schmunk; Romi Ghose; Maria A Croyle
Journal:  Expert Rev Vaccines       Date:  2021-03-18       Impact factor: 5.217

3.  Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

Authors:  Meng-Di Xia; Rui-Ran Yu; Dong-Ming Chen
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.